172 related articles for article (PubMed ID: 17605731)
1. The potential role of lactoferrin and derivatives in the management of infectious and inflammatory complications of hematology patients receiving a hematopoietic stem cell transplantation.
van der Velden WJ; Blijlevens NM; Donnelly JP
Transpl Infect Dis; 2008 Apr; 10(2):80-9. PubMed ID: 17605731
[TBL] [Abstract][Full Text] [Related]
2. Advances and challenges in infectious diseases supportive care of patients with hematologic malignancies, hematopoietic stem cell transplantation, and severe aplastic anemia.
Walsh TJ
Semin Hematol; 2009 Jul; 46(3):191-7. PubMed ID: 19549573
[TBL] [Abstract][Full Text] [Related]
3. Management of infections complicating allogeneic hematopoietic stem cell transplantation.
Hiemenz JW
Semin Hematol; 2009 Jul; 46(3):289-312. PubMed ID: 19549581
[TBL] [Abstract][Full Text] [Related]
4. The A-B-C of haematopoietic stem cell transplantation.
Rafeah NT; Fadilah SA
Med J Malaysia; 2009 Mar; 64(1):94-100; quiz 101. PubMed ID: 19852335
[TBL] [Abstract][Full Text] [Related]
5. Infectious complications in chronic graft-versus-host disease: a retrospective study of 145 recipients of allogeneic hematopoietic stem cell transplantation with reduced- and conventional-intensity conditioning regimens.
Yamasaki S; Heike Y; Mori S; Fukuda T; Maruyama D; Kato R; Usui E; Koido K; Kim S; Tanosaki R; Tobinai K; Teshima T; Takaue Y
Transpl Infect Dis; 2008 Jul; 10(4):252-9. PubMed ID: 18194371
[TBL] [Abstract][Full Text] [Related]
6. Infectious complication in 314 patients after high-dose therapy and autologous hematopoietic stem cell transplantation: risk factors analysis and outcome.
Gil L; Styczynski J; Komarnicki M
Infection; 2007 Dec; 35(6):421-7. PubMed ID: 17926001
[TBL] [Abstract][Full Text] [Related]
7. Graft-versus-host disease: review and nursing implications.
Mattson MR
Clin J Oncol Nurs; 2007 Jun; 11(3):325-8. PubMed ID: 17623617
[TBL] [Abstract][Full Text] [Related]
8. The contribution of endothelial activation and injury to end-organ toxicity following allogeneic hematopoietic stem cell transplantation.
Cooke KR; Jannin A; Ho V
Biol Blood Marrow Transplant; 2008 Jan; 14(1 Suppl 1):23-32. PubMed ID: 18162218
[TBL] [Abstract][Full Text] [Related]
9. [Clinical analysis of late-onset nephrotic syndrome after allogenic hematopoietic stem cell transplantation].
Luo XD; Liu QF; Ning J; Wei YQ; Fan ZP; Zhang Y; Sun J
Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(46):3280-3. PubMed ID: 18396625
[TBL] [Abstract][Full Text] [Related]
10. Rituximab therapy increased post-transplant cytomegalovirus complications in Non-Hodgkin's lymphoma patients receiving autologous hematopoietic stem cell transplantation.
Lee MY; Chiou TJ; Hsiao LT; Yang MH; Lin PC; Poh SB; Yen CC; Liu JH; Teng HW; Chao TC; Wang WS; Chen PM
Ann Hematol; 2008 Apr; 87(4):285-9. PubMed ID: 17943285
[TBL] [Abstract][Full Text] [Related]
11. Strategies to enhance immune function in hematopoietic transplantation recipients who have fungal infections.
Safdar A
Bone Marrow Transplant; 2006 Sep; 38(5):327-37. PubMed ID: 16915223
[TBL] [Abstract][Full Text] [Related]
12. Safety of hematopoietic stem cell transplantation in children less than three years of age.
Dvorak CC; Wright NB; Wong WB; Kristovich KM; Matthews EW; Weinberg KI; Amylon MD; Agarwal R
Pediatr Hematol Oncol; 2008 Dec; 25(8):705-22. PubMed ID: 19065437
[TBL] [Abstract][Full Text] [Related]
13. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
[TBL] [Abstract][Full Text] [Related]
14. Imaging of complications of hematopoietic stem cell transplantation.
Jagannathan JP; Ramaiya N; Gill RR; Alyea EP; Ros P
Radiol Clin North Am; 2008 Mar; 46(2):397-417, x. PubMed ID: 18619387
[TBL] [Abstract][Full Text] [Related]
15. Advances in hematopoietic stem cell transplantation for primary immunodeficiency.
Gennery AR; Cant AJ
Immunol Allergy Clin North Am; 2008 May; 28(2):439-56, x-xi. PubMed ID: 18424341
[TBL] [Abstract][Full Text] [Related]
16. The role of innate immunity in graft-versus-host disease and complications following allogeneic stem cell transplant.
Holler E
Biol Blood Marrow Transplant; 2009 Jan; 15(1 Suppl):59-61. PubMed ID: 19147080
[No Abstract] [Full Text] [Related]
17. An overview of chronic oral graft-vs-host disease following pediatric hematopoietic stem cell transplantation.
da Fonseca MA; Hong C
Pediatr Dent; 2008; 30(2):98-104. PubMed ID: 18481573
[TBL] [Abstract][Full Text] [Related]
18. [Human herpesvirus 7 infection in patients after allogeneic hematopoietic stem cell transplantation].
Wang LR; Dong LJ; Lu DP
Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(30):2113-6. PubMed ID: 17988530
[TBL] [Abstract][Full Text] [Related]
19. Preengraftment serum C-reactive protein (CRP) value may predict acute graft-versus-host disease and nonrelapse mortality after allogeneic hematopoietic stem cell transplantation.
Fuji S; Kim SW; Fukuda T; Mori S; Yamasaki S; Morita-Hoshi Y; Ohara-Waki F; Heike Y; Tobinai K; Tanosaki R; Takaue Y
Biol Blood Marrow Transplant; 2008 May; 14(5):510-7. PubMed ID: 18410893
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic growth factors including keratinocyte growth factor in allogeneic and autologous stem cell transplantation.
Seggewiss R; Einsele H
Semin Hematol; 2007 Jul; 44(3):203-11. PubMed ID: 17631184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
